Pfizer (NYSE:PFE) Slides as Weight Loss Drug Suffers Setback

Pfizer (NYSE:PFE) Slides as Weight Loss Drug Suffers Setback

admin December 7, 2023

Pharmaceutical and biotechnology giant Pfizer (NYSE:PFE) suffered a setback as it announced that it was...

Pfizer drops twice-daily version of obesity pill over side effects

admin December 5, 2023

<img loading="lazy" decoding="async"...

Pfizer drops weight-loss pill to rival Ozempic, Mounjaro

admin December 4, 2023

Pfizer Inc. is dropping development of an experimental weight-loss pill due to side...

Pfizer scraps twice-daily weight loss pill danuglipron after study shows ‘high rates’ of adverse side effects

admin December 3, 2023

Fox News medical contributor Dr. Marc...

Pfizer to discontinue twice-daily version of weight loss pill

admin December 2, 2023

<div role="button" tabindex="0" id="Placeholder-ArticleBody-Video-107341839" class="PlaceHolder-wrapper" data-vilynx-id="7000324414"...

FDA approves the active ingredient in Mounjaro to help people with obesity lose weight, named Zepbound

admin November 15, 2023

The U.S. Food and Drug Administration...

Eli Lilly’s Tirzepatide Weight-Loss Drug Gets FDA Approval

admin November 14, 2023

The FDA just approved a new injectable weight-loss drug from Eli Lilly.
It’s called...
Read More

FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy

admin November 13, 2023

The Food and Drug Administration on Wednesday approved Zepbound,...

Lilly weight-loss drug gets US, UK approval to rival Wegovy

admin November 12, 2023

<img loading="lazy" decoding="async"...

FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.

admin November 11, 2023

The decision by the Food and Drug Administration on Wednesday to...

weight loss remedies in kannada

Pfizer (NYSE:PFE) Slides as Weight Loss Drug Suffers Setback

Pfizer drops twice-daily version of obesity pill over side effects

Pfizer drops weight-loss pill to rival Ozempic, Mounjaro

Pfizer scraps twice-daily weight loss pill danuglipron after study shows ‘high rates’ of adverse side effects

Pfizer to discontinue twice-daily version of weight loss pill

FDA approves the active ingredient in Mounjaro to help people with obesity lose weight, named Zepbound

Eli Lilly’s Tirzepatide Weight-Loss Drug Gets FDA Approval

FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy

Lilly weight-loss drug gets US, UK approval to rival Wegovy

FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.

You may have missed